Latest news

• Pfizer/BioNTech confirm new global collaboration to develop first mRNA-based shingles vaccine

  The collaboration will see the two companies exploring new R&D and commercialisation in the hope of producing a preventative treatment for shingles – herpes zoster virus (HZV) – which is believed to ... HZV is a chronic type of varicella zoster virus

• GSK’s shingles vaccine Shingrix claims US approval

  Shingles is caused by the herpes zoster or varicella zoster virus (VZV), which causes chickenpox. ... While the immune system can generally shake off the symptoms of chickenpox, the virus lies dormant and if a person becomes immune-suppressed then the

• GSK's Shingrix sails through FDA advisory committee

  Shingles is caused by the herpes zoster or varicella zoster virus (VZV), which causes chickenpox. ... While the immune system can generally shake off the symptoms of chickenpox, the virus lies dormant and if a person becomes immune-suppressed can reawaken

• GSK's blockbuster hopeful Shingrix filed in US

  Shingles is a painful infection caused by varicella zoster virus (VZV), the chickenpox virus. ... While the immune system can generally shake off the symptoms of chickenpox, the virus lies dormant and if a person becomes immune-suppressed can reawaken,

• GSK throws gauntlet down to Merck with shingles vaccine data

  Shingles is an extremely painful infection caused by varicella zoster virus (VZV), the same one that causes chickenpox. ... GSK's vaccine is based on a protein called gE found on VZV, while Zostavaz is a live, attenuated form of the virus.